BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan L, Chen Y, Chen F, Tao T, Hu Z, Wang J, You J, Wong BCY, Chen J, Ye W. Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report From a Randomized Controlled Trial With 26.5 Years of Follow-up. Gastroenterology 2022;163:154-162.e3. [PMID: 35364066 DOI: 10.1053/j.gastro.2022.03.039] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu L, Wang Y, Zhao Y, Zhang W, Liu J, Wang F, Wang P, Tang X. Global knowledge mapping and emerging trends in research between spasmolytic polypeptide-expressing metaplasia and gastric carcinogenesis: A bibliometric analysis from 2002 to 2022. Front Cell Infect Microbiol 2023;12. [DOI: 10.3389/fcimb.2022.1108378] [Reference Citation Analysis]
2 Zhou XZ, Lyu NH, Zhu HY, Cai QC, Kong XY, Xie P, Zhou LY, Ding SZ, Li ZS, Du YQ; National Clinical Research Center for Digestive Diseases (Shanghai), Gastrointestinal Early Cancer Prevention & Treatment Alliance of China (GECA), Helicobacter pylori Study Group of Chinese Society of Gastroenterology and Chinese Alliance for Helicobacter pylori Study. Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention. Gut 2023:gutjnl-2022-328965. [PMID: 36690433 DOI: 10.1136/gutjnl-2022-328965] [Reference Citation Analysis]
3 Han Z, Liu J, Zhang W, Kong Q, Wan M, Lin M, Lin B, Ding Y, Duan M, Li Y, Zuo X, Li Y. Cardia and non-cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta-analysis, and estimation of population attributable fraction. Helicobacter 2023;:e12950. [PMID: 36645649 DOI: 10.1111/hel.12950] [Reference Citation Analysis]
4 Huang J, Lucero-Prisno DE 3rd, Zhang L, Xu W, Wong SH, Ng SC, Wong MCS. Updated epidemiology of gastrointestinal cancers in East Asia. Nat Rev Gastroenterol Hepatol 2023. [PMID: 36631716 DOI: 10.1038/s41575-022-00726-3] [Reference Citation Analysis]
5 Bai X, Ding SQ, Zhang XP, Han MH, Dai DQ. Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses. Cancers (Basel) 2023;15. [PMID: 36672322 DOI: 10.3390/cancers15020372] [Reference Citation Analysis]
6 Zou JC, Yang Y, Chen XZ; Sichuan Gastric Cancer Early Detection and Screening research group. Active Eradication of Helicobacter pylori Within Organized Massive Screening Might Improve Survival of Gastric Cancer Patients. Gastroenterology 2023;164:162-3. [PMID: 35550142 DOI: 10.1053/j.gastro.2022.05.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Xu X, Shu C, Wu X, Ouyang Y, Cheng H, Zhou Y, Wang H, He C, Xie C, He X, Hong J, Lu N, Ge Z, Zhu Y, Li N. A positive feedback loop of the TAZ/β-catenin axis promotes Helicobacter pylori-associated gastric carcinogenesis. Front Microbiol 2022;13:1065462. [PMID: 36620008 DOI: 10.3389/fmicb.2022.1065462] [Reference Citation Analysis]
8 Ramai D, Salati M, Pomati G, Amoroso C, Facciorusso A, Botticelli A, Ghidini M. Antibiotics, the microbiome and gastrointestinal cancers: A causal interference? Curr Opin Pharmacol 2022;67:102315. [PMID: 36351361 DOI: 10.1016/j.coph.2022.102315] [Reference Citation Analysis]
9 Hu Y, Zhu Y, Lu NH. The management of Helicobacter pylori infection and prevention and control of gastric cancer in China. Front Cell Infect Microbiol 2022;12:1049279. [PMID: 36530421 DOI: 10.3389/fcimb.2022.1049279] [Reference Citation Analysis]
10 Mei S, Deng Z, Chen Y, Ning D, Guo Y, Fan X, Wang R, Meng Y, Zhou Q, Tian X. Dysbiosis: The first hit for digestive system cancer. Front Physiol 2022;13. [DOI: 10.3389/fphys.2022.1040991] [Reference Citation Analysis]
11 Feng R, Su Q, Huang X, Basnet T, Xu X, Ye W. Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration? Cancer Commun (Lond) 2023;43:75-86. [PMID: 36397729 DOI: 10.1002/cac2.12393] [Reference Citation Analysis]
12 Jambi LK. Systematic Review and Meta-Analysis on the Sensitivity and Specificity of 13C/14C-Urea Breath Tests in the Diagnosis of Helicobacter pylori Infection. Diagnostics (Basel) 2022;12:2428. [PMID: 36292117 DOI: 10.3390/diagnostics12102428] [Reference Citation Analysis]
13 Yan L, Ye W. Reply. Gastroenterology 2022:S0016-5085(22)01033-2. [PMID: 36067816 DOI: 10.1053/j.gastro.2022.08.052] [Reference Citation Analysis]
14 Ford AC, Yuan Y, Moayyedi P. Long-Term Impact of Helicobacter pylori Eradication Therapy on Gastric Cancer Incidence and Mortality in Healthy Infected Individuals: A Meta-Analysis Beyond 10 Years of Follow-Up. Gastroenterology 2022;163:754-756.e1. [PMID: 35598628 DOI: 10.1053/j.gastro.2022.05.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li D. Understanding the Protective Effect of Helicobacter pylori Eradication on Gastric Cancer After a Quarter Century: New Insights From an Old Trial. Gastroenterology 2022;163:42-4. [PMID: 35500620 DOI: 10.1053/j.gastro.2022.04.038] [Reference Citation Analysis]
16 Kim Y, Choi IJ. Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening to Helicobacter pylori Eradication in Korea. J Gastric Cancer 2022;22:e22. [DOI: 10.5230/jgc.2022.22.e22] [Reference Citation Analysis]